Impact of Vitamin D Supplementation on Severity of Pediatric Atopic Dermatitis
NCT01996423 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101
Last updated 2015-03-03
Summary
The purpose of this study is to determine whether oral vitamin D supplementation improves the clinical severity of atopic dermatitis in children. In addition, this study plans to evaluate the effects of vitamin D supplementation on several key aspects of the immune system of children with atopic dermatitis.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Vitamin D3
- DIETARY_SUPPLEMENT
-
Placebo
Sponsors & Collaborators
-
Pontificia Universidad Catolica de Chile
lead OTHER
Principal Investigators
-
Arturo Borzutzky, M.D. · School of Medicine, Pontificia Universidad Católica de Chile
-
Carlos A Camargo Jr., M.D., DrPH · Massachusetts General Hospital, Harvard University, Boston, USA
-
Cristian Vera, M.D. · School of Medicine, Pontificia Universidad Católica de Chile
-
Lorena Cifuentes, M.D. · School of Medicine, Pontificia Universidad Católica de Chile
-
Sergio Silva, M.D. · School of Medicine, Pontificia Universidad Católica de Chile
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- Chile
Study Locations
More Related Trials
-
Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? the D-Vex Pilot Study
NCT03257215 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy of Topical Coal Tar in Children With Atopic Dermatitis
NCT03461302 ·Status: UNKNOWN ·Phase: PHASE4
-
Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit
NCT00654355 ·Status: COMPLETED ·Phase: PHASE4
-
Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children
NCT02519556 ·Status: COMPLETED ·Phase: PHASE4
-
Medium-Dose UVA1 Versus Narrow-Band UVB in Atopic Dermatitis
NCT00419406 ·Status: COMPLETED ·Phase: NA
-
A Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic Dermatitis
NCT01675232 ·Status: COMPLETED ·Phase: NA
-
Effects of Treatments on Atopic Dermatitis
NCT01631617 ·Status: RECRUITING ·Phase: PHASE2
-
The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitis
NCT00179959 ·Status: COMPLETED ·Phase: PHASE4
-
A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis
NCT04271514 ·Status: COMPLETED ·Phase: PHASE1
-
In-Use Tolerance Study Under Dermatological and Pediatric Controls of Sunscreen in Children With Atopic Dermatitis
NCT07194408 ·Status: COMPLETED
-
Effect of Oral Steroids on Skin Outcomes in Atopic Dermatitis
NCT02908698 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis
NCT00465699 ·Status: UNKNOWN ·Phase: NA
-
Effects of Lactobacillus Reuteri Plus Vitamin D3 in Children With Atopic Dermatitis
NCT02945683 ·Status: COMPLETED ·Phase: NA
-
A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)
NCT00932074 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis
NCT00125333 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients
NCT06397781 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life
NCT04900948 ·Status: COMPLETED ·Phase: PHASE4
-
Systemic Therapies for Pediatric Atopic Dermatitis
NCT01447381 ·Status: UNKNOWN
-
Clinical Trial to Evaluate the Effect of a Probiotic Mixture in the Treatment of Atopic Dermatitis in Children
NCT05443490 ·Status: TERMINATED ·Phase: NA
-
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis
NCT03646604 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
NCT03257644 ·Status: COMPLETED ·Phase: PHASE1
-
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
NCT03796676 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment
NCT00480896 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of Pediatric Skin Disorders: The "Big" Study
NCT03544866 ·Status: COMPLETED
-
Dietary Intervention on Atopy
NCT06547372 ·Status: RECRUITING ·Phase: NA